breast cancer

Despite the difficulties faced by mothers-to-be with cancer, a multidisciplinary treatment team at the JGH gives them good reason to hope for the best.

According to Dr. Michael Pollak of the Cancer Prevention Centre, the risk of cancer rises with the amount of alcohol consumed.

Study’s findings make a case for universal genetic testing of breast cancer patients.

After the devastating ice storm in January 1998, the JGH sheltered many people whose homes had lost electricity.

Dr. April Rose has joined the JGH as Attending Staff in the Division of Medical Oncology and in the Segal Cancer Centre.

Dr. William Foulkes, an expert in cancer genetics and a senior investigator at the Lady Davis Institute, has received the 2020 Wilder Penfield Prize for his research.

Three surgeons have been newly appointed at the JGH in Colorectal Surgery, General Surgery and Neurosurgery.

Dr. Mark Basik, a surgical oncologist at the JGH and a senior investigator in the Lady Davis Institute, has been appointed President of the Scientific Advisory Committee of the Cancer Research Society.

Approximately 3,011 people streamed through the streets of Montreal in August 2005 in the first Weekend to End Breast Cancer, giving a major boost to the treatment and prevention of breast cancer at the Segal Cancer Centre.

Dr. Michael Pollak, Director of the Stroll Cancer Prevention Centre at the JGH, has been chosen to serve as one of two leaders of a new Canada-wide team, aimed at translating fundamental research about breast cancer into effective treatment options for patients.